Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Tuesday's Intraday Session

 

Gainers

  • Artelo Biosciences (NASDAQ:ARTL) stock increased by 46.9% to $6.4 during Tuesday's regular session. Trading volume for Artelo Biosciences's stock is 14.9 million as of 13:30 EST. This is 18274.5% of its average full-day volume over the last 100 days. The company's market cap stands at $18.1 million.
  • Ventyx Biosciences (NASDAQ:VTYX) shares increased by 36.69% to $25.43. As of 13:30 EST, this security is trading at a volume of 960.6K shares, making up 477.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.2 billion. As per the press release, Q2 earnings came out yesterday.
  • Societal CDMO (NASDAQ:SCTL) stock increased by 28.78% to $1.7. As of 13:30 EST, this security is trading at a volume of 133.5K shares, making up 103.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $96.3 million. As per the press release, Q2 earnings came out 4 days ago.
  • Eargo (NASDAQ:EAR) shares increased by 27.19% to $1.45. The current volume of 8.3 million shares is 204.0% of Eargo's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $57.1 million.
  • Gritstone Bio (NASDAQ:GRTS) stock moved upwards by 21.03% to $4.93. The current volume of 5.7 million shares is 552.0% of Gritstone Bio's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $359.6 million.
  • Akumin (NASDAQ:AKU) shares moved upwards by 20.28% to $0.95. Akumin's stock is trading at a volume of 63.9K shares as of 13:30 EST. This is 76.4% of its average full-day volume over the last 100 days. The company's market cap stands at $85.0 million.

Losers

  • Sema4 Holdings (NASDAQ:SMFR) shares decreased by 30.0% to $1.68 during Tuesday's regular session. Trading volume for this security as of 13:30 EST is 4.5 million, which is 213.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $633.7 million. As per the press release, Q2 earnings came out yesterday.
  • T2 Biosystems (NASDAQ:TTOO) stock declined by 24.81% to $0.15. As of 13:30 EST, T2 Biosystems's stock is trading at a volume of 77.6 million, which is 248.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $26.4 million. As per the press release, Q2 earnings came out yesterday.
  • Albireo Pharma (NASDAQ:ALBO) stock decreased by 24.71% to $18.77. As of 13:30 EST, Albireo Pharma's stock is trading at a volume of 1.8 million, which is 648.3% of its average full-day volume over the last 100 days. The company's market cap stands at $367.4 million. As per the news, the Q2 earnings report came out yesterday.
  • CASI Pharmaceuticals (NASDAQ:CASI) stock decreased by 23.14% to $3.09. The current volume of 1.1 million shares is 317.4% of CASI Pharmaceuticals's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $42.0 million. The company's, Q2 earnings came out 2 days ago.
  • NanoVibronix (NASDAQ:NAOV) stock decreased by 17.25% to $0.6. As of 13:30 EST, NanoVibronix's stock is trading at a volume of 1.3 million, which is 1039.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $16.7 million.
  • Lucira Health (NASDAQ:LHDX) shares decreased by 15.87% to $2.81. Trading volume for Lucira Health's stock is 96.0K as of 13:30 EST. This is 124.5% of its average full-day volume over the last 100 days. The company's market cap stands at $112.0 million. As per the news, the Q2 earnings report came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.